Daehan Pharmaceutical

What Daehan Pharmaceutical does

Daehan Pharmaceutical (Dai Han Pharm. Co., Ltd., 대한약품공업주식회사) is a South Korean pharmaceutical manufacturer founded in 1945 and listed on KOSDAQ since 1994 under ticker 041650. The company specializes in infusion and injectable solutions, producing over 200 types of therapeutic drugs across prescription drugs, OTC products, dialysis solutions, and quasi-drugs. It pioneered Korea's first domestic infusion solution in 1953 and has since led container innovation including PVC bag (1989), ISPP (1992), Non-PVC bag (1998), and Multi-Chamber Bag (2001) technologies, with all manufacturing consolidated at a cGMP-compliant facility in Ansan-si (expanded 2015).

The business operates through three sales divisions — prescription products, medical products, and wholesale — supported by 10 regional branch offices across Korea (Seoul HQ plus Ansan, Busan, Gyeongnam, Daegu, Daejeon, Chungbuk, Gwangju, Jeonju, and Wonju), reaching hospitals, pharmacies, and dialysis centers. Customers include Korean healthcare institutions (Ministry of National Defense and other government channels historically), with revenue derived primarily from pharmaceutical manufacturing and sales under Korea's national health insurance reimbursement model. The company also exports infusion and injection products to Iraq, Vietnam, Japan, Mongolia, and Kazakhstan, and transferred special infusion technology to Kazakhstan in 2013.

Revenue was approximately KRW 72.6 billion in 2010 (8% growth) and KRW 100 billion in 2013, with the company controlled across three generations of the founding Lee family — founder Insil Lee (1945), Chairman Yoonwoo Lee (1992-), and current CEO Sungyoung Lee (2023-present). A prior joint venture in Tianjin, China was established in 1995 and closed in 1997, representing the company's only significant historical foreign subsidiary operation.

Name

Daehan Pharmaceutical

Legal name

Dai Han Pharm. Co., Ltd. (대한약품공업주식회사)

Website

https://daihan.com

Company type

Public

Founded year

1945

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Daehan Pharmaceutical is a KOSDAQ-listed South Korean manufacturer founded in 1945, specializing in infusion and injectable solutions with over 200 products sold to hospitals, pharmacies, and dialysis centers in Korea and select export markets including Iraq, Vietnam, Japan, and Mongolia.

Ownership category

akta.pro rank

Product category

Infusion and Injection Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Generic Finished Dosage Form (FDF) Manufacturing (HLAIABAH)

Keywords

• Infusion solutions
• Injection pharmaceuticals
• Parenteral nutrition
• Dialysis solutions
• Sterile pharmaceuticals

Headquarters

HQ city

Yongdungpo

HQ country

South Korea

HQ region

Asia

Offices10 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Manufacturing and Sales: Manufactures and sells over 200 types of pharmaceutical products including prescription drugs, OTC drugs, infusion solutions, injection solutions, dialysis solutions, and quasi-drugs through direct sales force and distribution networks in Korea. Also exports products to international markets including Iraq, Vietnam, Japan, and Mongolia.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels3 records

Core offering

Dai Han Pharm. manufactures and sells over 200 types of pharmaceutical products, primarily infusion solutions, injection solutions, OTC drugs, dialysis solutions, and quasi-drugs. The company is a specialist in infusion and injection parenteral pharmaceuticals, producing in diverse container formats including glass bottles, PVC bags, Non-PVC bags, PP bottles, and multi-chamber bags. Products are distributed through direct sales to hospitals and healthcare institutions across Korea, with international exports to markets including Iraq, Vietnam, Japan, and Mongolia.

Product overview

Daehan Pharmaceutical (대한약품공업주식회사) is an infusion and injectable solution-focused pharmaceutical manufacturer established in 1945, producing over 200 types of therapeutic drugs. The portfolio is organized across three product categories: Prescription Drugs (93+ products including sterile normal saline in various formats — 10mL syringes and 90mL bags, Daehan Plasma-Con compound electrolyte infusion, Ar Mix TPN amino acid injection, Daehan 5%/10%/20% glucose solutions and glucose-saline combinations, Daehan sterile irrigation water, and various injectable solutions such as Multi Supply 5 trace element injection, Seleniumin injection, Gamofril tablets, Glyfurol, Nephrisol, and Nutarihex); OTC Drugs (5 products including Daehan irrigation sterile normal saline, irrigation sterile water, sodium chloride solution, purified water); and Quasi-Drugs (Eyecon contact lens cleaning solution and Icon liquid). The company pioneered Korea's first domestic infusion solution in 1953 and manufactures in diverse container types (glass bottles, PP bottles, PVC bags, non-PVC bags, multi-chamber bags). Core business also includes exportation of infusion/injection drugs and transfer of plant-related technology.

Differentiator

Problem solved

Functional benefit

Products and services

• Sterile Normal Saline 10mL (대한멸균생리식염수 10mL) Sterile physiological saline solution in a polypropylene syringe (10mL, 50EA packaging) used for supply of water and electrolytes (sodium and chlorine deficiency) and as a diluent for injectable preparations.
• Sterile Normal Saline 90mL Kit (대한멸균생리식염수 90mL) Sterile physiological saline solution (0.9% sodium chloride) in a 90mL bag for supply of water and electrolytes and as a diluent for injectable preparations.
• Daehan Plasma-Con Injection (대한플라스콘주) Compound electrolyte infusion suitable for ECF (extracellular fluid) supplementation, used for replenishing reduced circulating blood volume and tissue fluid, and for correction of metabolic acidosis. Available in 1000mL and 500mL containers.
• Ar Mix Injection (아르믹스주) Total amino acid nutritional infusion optimized for TPN (Total Parenteral Nutrition) formulation, containing 16 essential and non-essential amino acids in a 250mL package.
• Multi Supply 5 Injection (멀티서플라이5주사) Injection providing trace elements including zinc, copper, manganese, chromium, and selenium for TPN solutions. Maintains plasma levels of essential trace elements during total parenteral nutrition.
• Seleniumin Injection (셀레노인주) Injection providing selenium supplementation for total parenteral nutrition (TPN), containing selenious acid equivalent to 40 mcg selenium per mL.
• Daehan 10% Glucose & Normal Saline Injection (대한10%포도당생리식염액) Combined 10% dextrose and normal saline infusion providing carbohydrate and electrolyte replacement.
• Daehan 20% Glucose Injection (대한20%포도당주사액) 20% dextrose (glucose) injection for carbohydrate supplementation.
• Gamofril Tablet (가모프리정)

Quantifiable outcome

• First infusion solution production in Korea (1953)
• +3 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• Korea Pharmaceutical Traders Association (한국의약품수출입협회)coreOthers · 1 January 2009Chairman Yoonwoo Lee elected as president of the Korea Pharmaceutical Traders Association in 2009, serving to advance the pharmaceutical export industry and represent Korean pharmaceutical companies internationally.

Scale indicators5 records

Recent moves9 records

Expansion highlights4 records

Broad incumbents

• Dong-A Pharmaceutical: Established Korean pharma with a broad portfolio of prescription and OTC products, including injectable products in overlapping hospital categories.
• Baxter International: Global leader in IV solutions, parenteral nutrition, and dialysis therapies; competes in Korea especially in specialty TPN multi-chamber bags and large-volume parenterals.
• Fresenius Kabi: Global supplier of IV drugs, infusion solutions, TPN, and clinical nutrition — competing with Daehan in Korean hospitals across electrolyte, amino acid, and trace element therapies.
• Yuhan Corporation: Large diversified Korean pharmaceutical company with broader therapeutic reach; overlaps with Daehan in select prescription injectables and hospital supply.
• B. Braun Melsungen: Global medical and infusion solutions manufacturer with established Korean subsidiary; competes directly in IV fluids, irrigation solutions, and clinical nutrition products.

Direct peers

• JW Pharmaceutical: Korean pharmaceutical manufacturer with a substantial IV solutions and electrolyte portfolio, directly competing in domestic infusion supply to hospitals and clinics.
• HK inno.N (formerly CJ Healthcare): Major Korean pharma with broad prescription and OTC portfolio including parenterals and electrolyte solutions; a direct competitor in the Korean infusion and injectable market.
• Daewon Pharmaceutical: Korean pharmaceutical manufacturer with prescription drug and IV solutions overlap, selling into the same Korean hospital channel as Daehan.

Emerging players

• ICU Medical: Specialist in IV therapy and infusion systems; relevant peer for parenteral container technology and clinical IV solution competition in Asian export markets.
• Daihan New Pharm: Smaller Korean pharmaceutical player with prescription drug manufacturing capabilities, competing for adjacent Korean hospital and OTC distribution slots.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks4 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Daehan Pharmaceutical